Literature DB >> 21436364

Ex vivo soft-laser treatment inhibits the synovial expression of vimentin and α-enolase, potential autoantigens in rheumatoid arthritis.

Géza Bálint1, Klára Barabás, Zsuzsanna Zeitler, József Bakos, Katalin A Kékesi, Akos Pethes, Erzsébet Nagy, Tamás Lakatos, Péter V Bálint, Zoltán Szekanecz.   

Abstract

BACKGROUND: Soft-laser therapy has been used to treat rheumatic diseases for decades. The major effects of laser treatment may be dependent not on thermal mechanisms but rather on cellular, photochemical mechanisms. However, the exact cellular and molecular mechanisms of action have not been elucidated.
OBJECTIVE: The aim of this study was to investigate the ex vivo effects of low-level laser treatment (with physical parameters similar to those applied previously) on protein expression in the synovial membrane in rheumatoid arthritis (RA).
DESIGN: Synovial tissues were laser irradiated, and protein expression was analyzed.
METHODS: Synovial membrane samples obtained from 5 people who had RA and were undergoing knee surgery were irradiated with a near-infrared diode laser at a dose of 25 J/cm(2) (a dose used in clinical practice). Untreated synovial membrane samples obtained from the same people served as controls. Synovial protein expression was assessed with 2-dimensional polyacrylamide gel electrophoresis followed by mass spectrometry.
RESULTS: The expression of 12 proteins after laser irradiation was different from that in untreated controls. Laser treatment resulted in the decreased expression of α-enolase in 2 samples and of vimentin and precursors of haptoglobin and complement component 3 in 4 samples. The expression of other proteins, including 70-kDa heat shock protein, 96-kDa heat shock protein, lumican, osteoglycin, and ferritin, increased after laser therapy. LIMITATIONS: The relatively small sample size was a limitation of the study.
CONCLUSIONS: Laser irradiation (with physical parameters similar to those used previously) resulted in decreases in both α-enolase and vimentin expression in the synovial membrane in RA. Both proteins have been considered to be important autoantigens that are readily citrullinated and drive autoimmunity in RA. Other proteins that are expressed differently also may be implicated in the pathogenesis of RA. Our results raise the possibility that low-level laser treatment of joints affected with RA may be effective, at least in part, by suppressing the expression of autoantigens. Further studies are needed.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21436364     DOI: 10.2522/ptj.20100065

Source DB:  PubMed          Journal:  Phys Ther        ISSN: 0031-9023


  4 in total

1.  Low-level laser therapy in different stages of rheumatoid arthritis: a histological study.

Authors:  Ana Carolina Araruna Alves; Paulo de Tarso Camillo de Carvalho; Marcio Parente; Murilo Xavier; Lucio Frigo; Flávio Aimbire; Ernesto Cesar Pinto Leal Junior; Regiane Albertini
Journal:  Lasers Med Sci       Date:  2012-04-27       Impact factor: 3.161

2.  Comparative evaluation of low-level laser and systemic steroid therapy in adjuvant-enhanced arthritis of rat temporomandibular joint: A histological study.

Authors:  Faezeh Khozeimeh; Ahmad Moghareabed; Maryam Allameh; Shahrzad Baradaran
Journal:  Dent Res J (Isfahan)       Date:  2015 May-Jun

Review 3.  Critical Role of Synovial Tissue-Resident Macrophage and Fibroblast Subsets in the Persistence of Joint Inflammation.

Authors:  Samuel Kemble; Adam P Croft
Journal:  Front Immunol       Date:  2021-09-03       Impact factor: 7.561

4.  Proteomic analysis of human osteoarthritis synovial fluid.

Authors:  Lavanya Balakrishnan; Raja Sekhar Nirujogi; Sartaj Ahmad; Mitali Bhattacharjee; Srikanth S Manda; Santosh Renuse; Dhanashree S Kelkar; Yashwanth Subbannayya; Rajesh Raju; Renu Goel; Joji Kurian Thomas; Navjyot Kaur; Mukesh Dhillon; Shantal Gupta Tankala; Ramesh Jois; Vivek Vasdev; Yl Ramachandra; Nandini A Sahasrabuddhe; Ts Keshava Prasad; Sujatha Mohan; Harsha Gowda; Subramanian Shankar; Akhilesh Pandey
Journal:  Clin Proteomics       Date:  2014-02-17       Impact factor: 3.988

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.